![Robert Kamen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Kamen
Director/Board Member at
HBM HOLDINGS LIMITED
Net worth: 7 M $ as of 2026-08-30
Profile
Dr. Robert I.
Kamen is a Senior Advisor at Shangbay Capital Management Co. LLC, an Independent Non-Executive Director at Harbour BioMed (Shanghai) Co., Ltd., an Independent Non-Executive Director at HBM Holdings Ltd., an Advisory Partner at Third Rock Ventures LLC and a Member at European Molecular Biology Organization.
He is on the Board of Directors at Harbour BioMed (Shanghai) Co., Ltd., HBM Holdings Ltd., EpimAb Biotherapeutics, Inc., Lycera Corp.
and Shanghai EpimAb Biotherapeutics Co. Ltd.
Dr. Kamen was previously employed as an Independent Director by Neon Therapeutics, Inc., an Independent Director by Jounce Therapeutics, Inc., a Board of Directors by Anchor Therapeutics, Inc., a Board Of Directors by Velocon Sports Inc, a Chairman by BioAssets Development Corp., a President by Abbot Bioresearch Center, Inc., a President by Abbott Bioresearch Center, a President by BASF Bioresearch Corp., and a Senior Vice President-Scientific Affairs by Genetics Institute, Inc. He also served on the board at Opsonic Therapeutics, Inc. and Harbour Antibodies BV.
He received his undergraduate degree from Amherst College and a doctorate degree from Harvard University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
HBM HOLDINGS LTD. 0.46% | 2025-12-30 | 4,128,040 ( 0.46% ) | 7 M $ | 2026-08-30 |
Robert Kamen active positions
| Companies | Position | Start |
|---|---|---|
| HBM HOLDINGS LIMITED | Director/Board Member | 2016-11-30 |
Harbour BioMed (Shanghai) Co., Ltd.
 Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Engages in discovering and developing innovative therapeutics for cancer | Director/Board Member | 2016-11-30 |
Shangbay Capital Management Co. LLC
 Shangbay Capital Management Co. LLC Investment ManagersFinance Shangbay Capital invests in companies located in the United States and globally. The firm targets companies operating in the fields of medical devices, biotechnology and healthcare technology services. It provides financing for early stage capital requirements. | Consultant / Advisor | 2021-03-10 |
European Molecular Biology Organization | Corporate Officer/Principal | 1975-12-31 |
Former positions of Robert Kamen
| Companies | Position | End |
|---|---|---|
| JOUNCE THERAPEUTICS, INC. | Director/Board Member | 2023-05-02 |
| NEON THERAPEUTICS, INC. | Director/Board Member | 2020-05-05 |
Harbour Antibodies BV
 Harbour Antibodies BV Medical/Nursing ServicesHealth Services Engages in the production of antibodies and VH domains for therapy | Director/Board Member | 2016-11-30 |
Opsonic Therapeutics, Inc. | Director/Board Member | 2014-05-31 |
Velocon Sports Inc | Director/Board Member | 2012-04-01 |
Training of Robert Kamen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
67
1st degree connections
18
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
BioAssets Development Corp.
 BioAssets Development Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Health Technology |
Lycera Corp.
 Lycera Corp. Pharmaceuticals: MajorHealth Technology Develops novel oral medicines for treating autoimmune diseases and cancer | Health Technology |
Anchor Therapeutics, Inc.
 Anchor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Designs and develops peptide modulators of G protein-coupled receptors | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amherst College
 Amherst College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
European Molecular Biology Organization | |
BASF Bioresearch Corp. | |
AbbVie Bioresearch Center, Inc.
 AbbVie Bioresearch Center, Inc. BiotechnologyHealth Technology Provides drug discovery, development sciences and biologics research services | Health Technology |
Harbour Antibodies BV
Harbour Antibodies BV Medical/Nursing ServicesHealth Services Engages in the production of antibodies and VH domains for therapy | Health Services |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immunotherapy company that develops therapies to treat cancer | Health Technology |
Opsonic Therapeutics, Inc. | |
BioNTech US, Inc.
 BioNTech US, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immunotherapies for cancer | Health Technology |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Engages in discovering and developing innovative therapeutics for cancer | Health Technology |
Shangbay Capital Management Co. LLC
Shangbay Capital Management Co. LLC Investment ManagersFinance Shangbay Capital invests in companies located in the United States and globally. The firm targets companies operating in the fields of medical devices, biotechnology and healthcare technology services. It provides financing for early stage capital requirements. | Finance |
EpimAb Biotherapeutics, Inc.
 EpimAb Biotherapeutics, Inc. MiscellaneousMiscellaneous Functions as an investment holding company | Miscellaneous |
HBM Holdings Ltd.
 HBM Holdings Ltd. Pharmaceuticals: OtherHealth Technology Engages in research and development of therapeutics in the fields of immuno-oncology and immunology diseases | Health Technology |
Velocon Sports Inc |
- Stock Market
- Insiders
- Robert Kamen
